Paul Workman on the challenges of cancer drug development. Interview by Katharine E. Pestell.
Workman
Paul
P
D000970:Antineoplastic Agents; D015195:Drug Design; D004345:Drug Industry; D012106:Research
D000970:Antineoplastic Agents